Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Vaccine ; 2022.
Article in English | ScienceDirect | ID: covidwho-1778489

ABSTRACT

Objective To evaluate the factors associated with the intention to participate in COVID-19 vaccine clinical trials in the Peruvian population. Methods Cross-sectional study and secondary analysis of a database that involved Peruvian population during September 2020. The Poisson regression model was used to estimate the associated factors. Results Data from 3231 individuals were analyzed, 44.1% of whom intended to participate in COVID-19 vaccine clinical trials. Factors associated with the outcome were being male (RPa: 1.25;95% CI: 1.15–1.35), being from the highlands region (RPa: 1.18;95% CI: 1.09–1.28) or jungle (RPa: 1.30;95% CI: 1.15–1.47), having a relative that is a healthcare professional (PRa: 1.16;95% CI: 1.06–1.28), using a medical source of information (PRa: 1.28;95% CI: 1.17–1.41), and trusting in the possible effectiveness of vaccines (PRa: 1.40;95% CI: 1.29–1.51). The main reason for not participating in the trial was the possibility of developing side effects (69.80%). Conclusion There is an urgent need to generate a perception of safety in COVID-19 vaccine clinical trials, to increase the population's intention to participate in these studies, and to provide evidence-based information about the vaccine.

2.
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo ; 14(Supl. 1): 13-21, oct. 21, 2021.
Article in Spanish, English | WHO COVID, LILACS (Americas) | ID: covidwho-1529100

ABSTRACT

Objetivo: Describir las prácticas de prevención y control para la infección por SARS-CoV2 en la población peruana. Material y Métodos: Estudio observacional de tipo descriptivo. Se evaluó una muestra no probabilística de adultos residentes en algún departamento de Perú. Las prácticas preventivas fueron evaluadas en personas sin antecedente de COVID-19 y las prácticas de control en personas que lo habían padecido. Resultados: Se evaluó un total de 3630 peruanos (edad media 25,4 ± 9,5) de los cuales el 3231 no indicaban el antecedente de COVID-19 y 399 refirieron haberlo padecido. Las medidas de prevención y control que se realizaron a menudo o siempre con mayor frecuencia fueron el utilizar mascarilla al salir de casa (97,9% vs 87,7), cubrirse su nariz y boca al estornudar o toser (95,4% vs 89,9%), guardar distancia de los demás en la calle (91,4% vs 74,7%), realizar el lavado de manos con agua y jabón al volver a casa (92,5% vs 88,7%), y desinfectar las superficies de objetos y lugares personales (82,6% vs 77,4%). El 22,1% y 83,7%, el 59,7% y 80,2, y el 8,0% y 16,8% consumieron algún tipo de medicamento, planta medicinal y dióxido de cloro para la prevención y control de la infección de COVID-19, respectivamente. Conclusiones: En general, menos del 50% de los participantes realizaron prácticas de prevención y control frente a la COVID-19 a menudo o siempre.


Objective: To describe prevention and control practices for SARS-CoV2 infection in the Peruvian population. Material and Methods: Observational descriptive study. A non-probabilistic sample of adults residing in a Peruvian department was evaluated. Preventive practices were evaluated in people with no history of COVID-19 and control practices in people who had had COVID-19. Results: A total of 3630 Peruvians were evaluated (mean age 25.4 ± 9.5) of whom 3231 did not indicate a history of COVID-19 and 399 reported having suffered from it. The prevention and control measures most frequently or always performed were using a mask when leaving home (97.9% vs 87.7%), covering their nose and mouth when sneezing or coughing (95.4% vs 89.9%), keeping their distance from others in the street (91.4% vs 74.7%), washing hands with soap and water when returning home (92.5% vs 88.7%), and disinfecting surfaces of objects and personal places (82.6% vs 77.4%). 22.1% and 83.7%, 59.7% and 80.2, and 8.0% and 16.8% consumed some type of medication, medicinal plant, and chlorine dioxide for prevention and control of COVID-19 infection, respectively. Conclusions: Overall, less than 50% of the participants performed prevention and control practices against COVID-19 often or always.

SELECTION OF CITATIONS
SEARCH DETAIL